Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

This therapy effectively treats resistant alopecia areata with minimal side effects.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

The document concludes that early recognition and appropriate treatment of red scalp, red ear, and red scrotum syndromes can lead to remission.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

Certain hormone treatments can improve acne and related conditions in women.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

A 37-year-old man with hair loss and skin issues was successfully treated with oral antibiotics, highlighting the need for early treatment. Long-term care includes low-dose antibiotics and avoiding caps and wigs.

No single treatment is clearly effective for central serous chorioretinopathy.

Combining methotrexate and corticosteroids can effectively regrow hair in severe alopecia areata.

Early treatment with corticosteroids and immunosuppressants is crucial for managing Vogt-Koyanagi-Harada disease.

Pediatric pemphigus is often diagnosed late, but rituximab helps control it long-term.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Injecting steroids like Triamcinolone Acetonide for skin treatments can cause Cushing's Syndrome.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

New therapies are needed to reduce the burden of alopecia areata.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.